Donate For Public and Patients Store Search

U003 - Principles of CTCL Management: What's the Evidence?

Friday, March 1; 7:30 AM - 8:30 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Identify challenges in patient management in cutaneous T-cell lymphoma
  • Review evidence-based data and consensus guidelines to guide management decisions

Description

This interactive session will focus on 3 common challenging management issues that arise in caring for CTCL patients. We will review published evidence-based data and consensus guidelines using a multidisciplinary approach: 1) Management and prognosis of folliculotropic mycosis fungoides/CTCL; 2) Traditional vs low dose radiation therapy in CTCL; 3) Impact of immunosuppressive medications in MF/CTCL.

Disclosures

  • Haun, Paul, MD, MS: Health Press, Inc – O(IP);
  • Kim, Ellen J., MD: Actelion – I(Grants/Research Funding); Galderma USA – C(H), I(Grants/Research Funding); Helsinn Healthcare – C(H); Kyowa Hakko Kirin Pharma, Inc. – I(Grants/Research Funding); Medimmune – I(Grants/Research Funding); Solgenix LLC – I(Grants/Research Funding);
  • Sahni, Debjani, MBBS, MD: no financial relationships exist with commercial interests.
Schedule
Friday, March 1
7:30 AM
Dr. Kim / Traditional vs low dose radiation in CTCL
7:45 AM
Dr. Sahni / Management and prognosis of folliculotropic MF/CTCL
8:00 AM
Dr. Haun / What is the impact of immunosuppressive medications in CTCL?
8:15 AM
All faculty / Panel Discussion
Event Details
  • Date
    Friday, March 1
  • Time
    7:30 AM - 8:30 AM
  • Location
    Room 208A
  • CME Credits
    1.00
  • Type
Directors/Co-Directors
  • Ellen J. Kim, MD, FAAD
Speakers
  • Debjani Sahni, MBBS, MD
  • Paul Haun, MD, MS, FAAD